129 related articles for article (PubMed ID: 25332266)
1. m-RECIST at 1 month and Child A are survival predictors after percutaneous ethanol injection of hepatocellular carcinoma.
Silva MF; Carrilho FJ; Paranaguá-Vezozzo DC; Campos LT; Nacif LS; Diniz MA; Farias AQ; Alves VA; D'Alburquerque LA; Ono SK
Ann Hepatol; 2014; 13(6):796-802. PubMed ID: 25332266
[TBL] [Abstract][Full Text] [Related]
2. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
Dettmer A; Kirchhoff TD; Gebel M; Zender L; Malek NP; Panning B; Chavan A; Rosenthal H; Kubicka S; Krusche S; Merkesdal S; Galanski M; Manns MP; Bleck JS
World J Gastroenterol; 2006 Jun; 12(23):3707-15. PubMed ID: 16773687
[TBL] [Abstract][Full Text] [Related]
3. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis.
Tanaka K; Nakamura S; Numata K; Kondo M; Morita K; Kitamura T; Saito S; Kiba T; Okazaki H; Sekihara H
Cancer; 1998 Jan; 82(1):78-85. PubMed ID: 9428482
[TBL] [Abstract][Full Text] [Related]
4. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.
Andriulli A; de Sio I; Solmi L; De Carlis L; Troisi R; Grasso A; Festa V; Caturelli E; Giacomoni A; Del Vecchio Blanco C; De Hemptinne B; Burroughs A; Perri F
Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162
[TBL] [Abstract][Full Text] [Related]
5. Local injection therapy for hepatocellular carcinoma.
Lin XD; Lin LW
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):16-21. PubMed ID: 16481276
[TBL] [Abstract][Full Text] [Related]
6. Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.
Mazzanti R; Arena U; Pantaleo P; Antonuzzo L; Cipriani G; Neri B; Giordano C; Lanini F; Marchetti S; Gentilini P
Can J Gastroenterol; 2004 Oct; 18(10):611-8. PubMed ID: 15497001
[TBL] [Abstract][Full Text] [Related]
7. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study.
Huo TI; Huang YH; Wu JC; Lee PC; Chang FY; Lee SD
Scand J Gastroenterol; 2003 Jul; 38(7):770-8. PubMed ID: 12889565
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation.
Ebara M; Okabe S; Kita K; Sugiura N; Fukuda H; Yoshikawa M; Kondo F; Saisho H
J Hepatol; 2005 Sep; 43(3):458-64. PubMed ID: 16005538
[TBL] [Abstract][Full Text] [Related]
9. Single hepatocellular carcinoma smaller than 2 cm: are ethanol injection and radiofrequency ablation equally effective?
Pompili M; De Matthaeis N; Saviano A; De Sio I; Francica G; Brunello F; Cantamessa A; Giorgio A; Scognamiglio U; Fornari F; Giangregorio F; Piscaglia F; Gualandi S; Caturelli E; Roselli P; Riccardi L; Rapaccini GL
Anticancer Res; 2015 Jan; 35(1):325-32. PubMed ID: 25550567
[TBL] [Abstract][Full Text] [Related]
10. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD
J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
12. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations.
Wong SN; Lin CJ; Lin CC; Chen WT; Cua IH; Lin SM
AJR Am J Roentgenol; 2008 Mar; 190(3):W187-95. PubMed ID: 18287411
[TBL] [Abstract][Full Text] [Related]
13. [Percutaneous ethanol injection (PEI) for small hepatocellular carcinoma].
Ebara M; Kita K; Nagato Y; Yoshikawa M; Sugiura N; Ohto M
Gan To Kagaku Ryoho; 1993 May; 20(7):884-8. PubMed ID: 8387759
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Pompili M; Rapaccini GL; de Luca F; Caturelli E; Astone A; Siena DA; Villani MR; Grattagliano A; Cedrone A; Gasbarrini G
Cancer; 1997 Apr; 79(8):1501-8. PubMed ID: 9118030
[TBL] [Abstract][Full Text] [Related]
15. CT imaging findings in patients with advanced hepatocellular carcinoma treated with sorafenib: Alternative response criteria (Choi, European Association for the Study of the Liver, and modified Response Evaluation Criteria in Solid Tumor (mRECIST)) versus RECIST 1.1.
Gavanier M; Ayav A; Sellal C; Orry X; Claudon M; Bronowicki JP; Laurent V
Eur J Radiol; 2016 Jan; 85(1):103-112. PubMed ID: 26724654
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study.
Tsai WL; Cheng JS; Lai KH; Lin CP; Lo GH; Hsu PI; Yu HC; Lin CK; Chan HH; Chen WC; Chen TA; Li WL; Liang HL
Aliment Pharmacol Ther; 2008 Aug; 28(3):304-11. PubMed ID: 19086330
[TBL] [Abstract][Full Text] [Related]
17. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients.
Lencioni R; Bartolozzi C; Caramella D; Paolicchi A; Carrai M; Maltinti G; Capria A; Tafi A; Conte PF; Bevilacqua G
Cancer; 1995 Nov; 76(10):1737-46. PubMed ID: 8625042
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma.
Luo BM; Wen YL; Yang HY; Zhi H; Xiao XY; Ou B; Pan JS; Ma JH
World J Gastroenterol; 2005 Oct; 11(40):6277-80. PubMed ID: 16419155
[TBL] [Abstract][Full Text] [Related]
19. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder.
Huang H; Liang P; Yu XL; Cheng ZG; Han ZY; Yu J; Liu FY
Int J Hyperthermia; 2015 Feb; 31(1):40-7. PubMed ID: 25766386
[TBL] [Abstract][Full Text] [Related]
20. Intralesional ethanol in the treatment of unresectable liver cancer.
Livraghi T; Lazzaroni S; Meloni F; Torzilli G; Vettori C
World J Surg; 1995; 19(6):801-6. PubMed ID: 8553669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
